Quest Diagnostics - DGX Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $150.91
Forecasted Upside: 6.66%
Number of Analysts: 10
Breakdown:
1 Sell Ratings
6 Hold Ratings
3 Buy Ratings
0 Strong Buy Ratings

^$141.48 As of 03/31/2023 01:00 AM ET

▲ +2.19 (1.57%)

1 month | 3 months | 12 months

Get New Quest Diagnostics Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for DGX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DGX

^$150.91

▲ +6.66% Upside Potential

This price target is based on 10 analysts offering 12 month price targets for Quest Diagnostics in the last 3 months. The average price target is $150.91, with a high forecast of $165.00 and a low forecast of $125.00. The average price target represents a 6.66% upside from the last price of $141.48.

Current Consensus is Hold

The current consensus among 10 investment analysts is to hold stock in Quest Diagnostics. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
3 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

10/8/2021

0 strong buy ratings
2 buy ratings
7 hold ratings
1 sell ratings

Ratings as of

1/6/2022

0 strong buy ratings
2 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

4/6/2022

0 strong buy ratings
3 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

7/5/2022

0 strong buy ratings
2 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

10/3/2022

0 strong buy ratings
3 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

1/1/2023

0 strong buy ratings
3 buy ratings
5 hold ratings
1 sell ratings

Ratings as of

3/2/2023

0 strong buy ratings
3 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

4/1/2023

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/17/2023	Mizuho	Reiterated Rating	Buy	$165.00	Low
3/17/2023	Truist Financial	Lower Target	Hold	$170.00 ➝ $160.00	Low
2/3/2023	Wells Fargo & Company	Boost Target	Equal Weight	$135.00 ➝ $140.00	Low
1/25/2023	Credit Suisse Group	Boost Target	Neutral	$143.00 ➝ $146.00	Low
1/23/2023	Evercore ISI	Initiated Coverage	Inline	$159.00	Low
1/12/2023	Robert W. Baird	Boost Target	Neutral	$143.00 ➝ $154.00	Low
1/6/2023	Morgan Stanley	Boost Target	Equal Weight	$146.00 ➝ $158.00	Low
12/14/2022	Mizuho	Boost Target	Buy	$160.00 ➝ $165.00	Low
11/17/2022	Citigroup	Downgrade	Neutral ➝ Sell	$145.00 ➝ $125.00	Low
10/21/2022	Morgan Stanley	Boost Target	Equal Weight	$142.00 ➝ $146.00	Low
10/21/2022	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$129.00 ➝ $140.00	Low
10/20/2022	William Blair	Reiterated Rating	Outperform		Low
8/22/2022	Morgan Stanley	Reiterated Rating	Equal Weight	$142.00	Low
4/25/2022	Wells Fargo & Company	Boost Target	Equal Weight	$145.00 ➝ $150.00	Medium
4/24/2022	UBS Group	Boost Target		$139.00 ➝ $150.00	Low
4/22/2022	Bank of America	Lower Target	Buy	$166.00 ➝ $163.00	High
4/4/2022	Citigroup	Downgrade	Buy ➝ Neutral	$175.00 ➝ $140.00	Low
2/23/2022	UBS Group	Downgrade	Buy ➝ Neutral	$160.00 ➝ $139.00	Medium
2/14/2022	Morgan Stanley	Lower Target	Equal Weight	$159.00 ➝ $145.00	High
2/4/2022	Wells Fargo & Company	Lower Target	Equal Weight	$160.00 ➝ $145.00	Medium
2/4/2022	Robert W. Baird	Lower Target		$162.00 ➝ $146.00	Medium
2/2/2022	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$135.00	Medium
1/28/2022	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$190.00 ➝ $129.00	Medium
1/19/2022	Truist Financial	Lower Target		$170.00 ➝ $160.00	Low
1/13/2022	Robert W. Baird	Lower Target		$173.00 ➝ $162.00	High
1/10/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$160.00 ➝ $190.00	High
1/5/2022	Truist Financial	Boost Target		$150.00 ➝ $170.00	High
12/17/2021	Morgan Stanley	Lower Target	Equal Weight	$165.00 ➝ $159.00	Low
12/14/2021	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$150.00 ➝ $160.00	Medium
12/13/2021	KeyCorp	Boost Target	Overweight	$168.00 ➝ $170.00	High
10/26/2021	Wells Fargo & Company	Boost Target	Equal Weight	$140.00 ➝ $150.00	Low
10/22/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$150.00 ➝ $160.00	Low
9/10/2021	Citigroup	Boost Target	Buy	$158.00 ➝ $181.00	High
9/1/2021	KeyCorp	Boost Target	In-Line ➝ Overweight	$144.00 ➝ $168.00	Low
8/31/2021	Morgan Stanley	Boost Target	Equal Weight	$136.00 ➝ $165.00	High
8/19/2021	Mizuho	Boost Target	Buy	$158.00 ➝ $166.00	High
8/13/2021	Credit Suisse Group	Boost Target	Neutral	$135.00 ➝ $150.00	Low
7/23/2021	Jefferies Financial Group	Initiated Coverage	Buy	$160.00	Low
5/12/2021	Mizuho	Boost Target	Buy	$149.00 ➝ $158.00	Medium
5/4/2021	UBS Group	Upgrade	Neutral ➝ Buy	$135.00 ➝ $158.00	High
3/18/2021	Robert W. Baird	Reiterated Rating	Outperform ➝ Neutral	$137.00	Low
3/12/2021	Morgan Stanley	Boost Target	Equal Weight	$130.00 ➝ $136.00	Low
3/12/2021	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$137.00	Low
1/29/2021	Citigroup	Boost Target		$151.00 ➝ $158.00	Low
12/17/2020	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight		Low
10/26/2020	Mizuho	Boost Target	Buy	$144.00 ➝ $149.00	Medium
10/23/2020	Wells Fargo & Company	Reiterated Rating	Hold		Low
10/21/2020	Argus	Upgrade	Hold ➝ Buy	$135.00	Medium
10/14/2020	Jefferies Financial Group	Boost Target	Buy	$125.00 ➝ $134.00	Medium
7/24/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Top Pick ➝ Buy	$140.00 ➝ $150.00	Medium
7/24/2020	Mizuho	Boost Target	Buy	$114.00 ➝ $144.00	Medium
7/24/2020	Citigroup	Boost Target	Buy	$130.00 ➝ $151.00	Medium
7/14/2020	Credit Suisse Group	Boost Target	Neutral	$126.00 ➝ $128.00	High
7/14/2020	Bank of America	Upgrade	Neutral ➝ Buy	$142.00	High
6/9/2020	Wells Fargo & Company	Upgrade	Underweight ➝ Equal Weight	$90.00 ➝ $120.00	Low
6/1/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$140.00	High
5/21/2020	SunTrust Banks	Boost Target	Hold	$110.00 ➝ $130.00	Low
5/20/2020	Morgan Stanley	Boost Target	Overweight	$139.00 ➝ $146.00	Medium
5/5/2020	UBS Group	Boost Target	Neutral	$106.00 ➝ $111.00	Low
4/30/2020	Bank of America	Boost Target	Neutral	$105.00 ➝ $120.00	Low
4/28/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$95.00 ➝ $139.00	High
4/27/2020	Wolfe Research	Upgrade	Underperform ➝ Market Perform	$116.00	Medium
4/27/2020	Citigroup	Upgrade	Neutral ➝ Buy	$113.00 ➝ $130.00	High
4/24/2020	Credit Suisse Group	Reiterated Rating	Hold	$100.00	Low
4/23/2020	JPMorgan Chase & Co.	Boost Target	Neutral	$87.00 ➝ $111.00	Medium
4/23/2020	SunTrust Banks	Boost Target	Hold	$100.00 ➝ $110.00	Low
4/23/2020	Barclays	Boost Target	Equal Weight	$93.00 ➝ $99.00	Low
4/23/2020	Wells Fargo & Company	Boost Target	Underweight	$80.00 ➝ $90.00	Low
4/22/2020	Cfra	Downgrade	Strong-Buy ➝ Hold	$140.00 ➝ $106.00	Medium
4/16/2020	Mizuho	Lower Target	Buy	$110.00 ➝ $106.00	Medium
4/13/2020	SunTrust Banks	Lower Target	Hold	$115.00 ➝ $100.00	Low
4/2/2020	JPMorgan Chase & Co.	Lower Target	Neutral	$99.00 ➝ $87.00	Low
3/30/2020	Wells Fargo & Company	Lower Target	Underweight	$100.00 ➝ $80.00	Low
3/27/2020	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$95.00	High
3/26/2020	Barclays	Lower Target	Equal Weight	$106.00 ➝ $93.00	Low
3/5/2020	Cfra	Upgrade	Hold ➝ Strong-Buy	$116.00 ➝ $140.00	Low
2/10/2020	Mizuho	Boost Target	Buy	$116.00 ➝ $122.00	Low
2/3/2020	Citigroup	Boost Target	Neutral	$110.00 ➝ $113.00	Low
1/31/2020	Bank of America	Boost Target	Neutral	$110.00 ➝ $116.00	Low
1/31/2020	Robert W. Baird	Boost Target	Outperform	$113.00 ➝ $118.00	Low
1/30/2020	Piper Sandler	Boost Target	Hold	$102.00 ➝ $107.00	Low
1/7/2020	Wells Fargo & Company	Initiated Coverage	Underweight	$100.00	Low
1/7/2020	Barclays	Downgrade	Overweight ➝ Equal Weight	$106.00	Medium
1/3/2020	Bank of America	Downgrade	Neutral ➝ Underperform		Low
12/19/2019	Bank of America	Upgrade	Underperform ➝ Neutral	$94.00 ➝ $110.00	Low
10/21/2019	UBS Group	Lower Target	Neutral	$103.00 ➝ $102.00	Low
8/23/2019	Morgan Stanley	Boost Target	Overweight	$111.00 ➝ $121.00	High
8/8/2019	Evercore ISI	Reiterated Rating	Buy	$108.00	Low
7/24/2019	JPMorgan Chase & Co.	Boost Target	Neutral	$100.00 ➝ $111.00	Low
7/24/2019	Morgan Stanley	Boost Target	Overweight	$104.00 ➝ $111.00	Low
7/24/2019	Credit Suisse Group	Boost Target	Neutral	$99.00 ➝ $105.00	Low
7/15/2019	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell	$90.00 ➝ $85.00	High
5/20/2019	Mizuho	Set Target	Buy	$110.00	Low
4/25/2019	Morgan Stanley	Boost Target	Overweight ➝ Overweight	$98.00 ➝ $104.00	Low
4/24/2019	UBS Group	Boost Target	Neutral	$91.00 ➝ $99.00	Low
4/24/2019	Citigroup	Boost Target	Neutral	$93.00 ➝ $102.00	Medium
4/2/2019	Wolfe Research	Initiated Coverage	Underperform		Low
4/2/2019	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$93.00 ➝ $107.00	Low
3/18/2019	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$101.00 ➝ $91.00	Low
2/19/2019	Credit Suisse Group	Lower Target	Outperform ➝ Outperform	$103.00 ➝ $101.00	Low
2/15/2019	Mizuho	Set Target	Buy	$106.00	Low
2/15/2019	UBS Group	Set Target	Hold	$91.00	Low
2/15/2019	Barclays	Reiterated Rating	Buy	$114.00	Low
2/14/2019	Piper Jaffray Companies	Lower Target	Neutral	$110.00 ➝ $100.00	High
1/31/2019	Argus	Downgrade	Buy ➝ Hold		Medium
1/17/2019	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$90.00	Low
1/3/2019	Bank of America	Downgrade	Neutral ➝ Underperform		Medium
12/20/2018	Morgan Stanley	Set Target	Buy	$101.00	Medium
12/9/2018	The Goldman Sachs Group	Lower Target	Buy ➝ Neutral	$110.00 ➝ $90.00	Low
12/3/2018	SunTrust Banks	Lower Target	Hold ➝ Positive	$96.00	Medium
12/3/2018	Bank of America	Downgrade	Buy ➝ Neutral		Medium
12/2/2018	Credit Suisse Group	Reiterated Rating	Buy	$121.00	Medium
11/30/2018	Barclays	Lower Target	Overweight ➝ Overweight	$125.00 ➝ $117.00	Low
11/30/2018	Craig Hallum	Reiterated Rating	Hold	$94.00	Medium
11/30/2018	Credit Suisse Group	Lower Target	Outperform ➝ Outperform	$121.00 ➝ $103.00	Medium
11/30/2018	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$120.00 ➝ $107.00	Medium
11/30/2018	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$110.00 ➝ $90.00	Low
11/20/2018	Mizuho	Set Target	Buy	$108.00	Medium
10/24/2018	Argus	Set Target	Buy	$106.00	Low
10/24/2018	Barclays	Lower Target	Overweight ➝ Overweight	$130.00 ➝ $125.00	Medium
10/24/2018	Credit Suisse Group	Lower Target	Outperform ➝ Outperform	$128.00 ➝ $121.00	High
10/24/2018	Citigroup	Lower Target	Neutral ➝ Neutral	$112.00 ➝ $104.00	High
10/24/2018	JPMorgan Chase & Co.	Lower Target	Neutral ➝ Neutral	$114.00 ➝ $107.00	High
10/23/2018	William Blair	Reiterated Rating	Outperform		Low
10/19/2018	Bank of America	Initiated Coverage	Buy ➝ Buy		Low
9/24/2018	Credit Suisse Group	Boost Target	Outperform	$121.00 ➝ $128.00	Low
9/14/2018	Argus	Set Target	Buy	$116.00 ➝ $120.00	Low
7/10/2018	Evercore ISI	Upgrade	In-Line ➝ Outperform	$103.00	High
6/27/2018	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$108.00	High
6/25/2018	Barclays	Upgrade	Equal Weight ➝ Overweight	$120.00 ➝ $130.00	High
6/8/2018	William Blair	Upgrade	Market Perform ➝ Outperform		High
5/29/2018	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$120.00	Low
5/28/2018	Barclays	Reiterated Rating	Hold	$120.00	Low
5/25/2018	Credit Suisse Group	Boost Target	Outperform ➝ Outperform	$118.00 ➝ $121.00	Low
5/25/2018	Mizuho	Reiterated Rating	Buy		High
5/1/2018	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$115.00	Medium

(Data available from 4/1/2018 forward)

News Sentiment Rating

0.88 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

7 very positive mentions
21 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

9/3/2022

5 very positive mentions
13 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

10/3/2022

21 very positive mentions
32 positive mentions
2 negative mentions
2 very negative mentions

Mentions as of

11/2/2022

13 very positive mentions
19 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

12/2/2022

7 very positive mentions
8 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

1/1/2023

17 very positive mentions
15 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

1/31/2023

21 very positive mentions
39 positive mentions
3 negative mentions
0 very negative mentions

Mentions as of

3/2/2023

25 very positive mentions
20 positive mentions
0 negative mentions
1 very negative mentions

Mentions as of

4/1/2023

Current Sentiment

Recent Stories by Sentiment

Very Negative

finance.yahoo.com
3/29/2023
The Los Angeles County Department of Public Health Joins Forces With Quest for Health Equity To Supply Blood Lead Testing at No Charge in the Exide Area

Negative

No negative mentions tracked during this time.

Positive

marketwatch.com
3/28/2023
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day
americanbankingnews.com
3/24/2023
Quest Diagnostics (NYSE:DGX) Issues FY 2023 Earnings Guidance
americanbankingnews.com
3/23/2023
Analysts Set Quest Diagnostics Incorporated (NYSE:DGX) PT at $150.91
finance.yahoo.com
3/22/2023
Sesame Workshop Launches New Resources for Parents, Caregivers, and Healthcare Providers Addressing Health and Well-Being Inequities, With Support From Quest Diagnostics
seekingalpha.com
3/21/2023
Quest Diagnostics Remains A Solid Long-Term Company

Very Positive

marketbeat.com
3/31/2023
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Bank of Montreal Can
marketbeat.com
3/30/2023
Montecito Bank & Trust Invests $247,000 in Quest Diagnostics Incorporated (NYSE:DGX)
finance.yahoo.com
3/29/2023
Quest Diagnostics (DGX) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com
3/29/2023
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)
marketbeat.com
3/29/2023
1,444 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Prairiewood Capital LLC

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Today's Range

Now: $141.48

$139.75

$141.76

50 Day Range

MA: $141.21

$131.53

$148.64

52 Week Range

Now: $141.48

$120.40

$158.34

Volume

919,140 shs

Average Volume

1,366,617 shs

Market Capitalization

$15.75 billion

P/E Ratio

17.86

Dividend Yield

1.91%

Beta

0.95

Frequently Asked Questions

What sell-side analysts currently cover shares of Quest Diagnostics?: The following sell-side analysts have issued research reports on Quest Diagnostics in the last twelve months: Bank of America Co., Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Mizuho, Morgan Stanley, Robert W. Baird, StockNews.com, Truist Financial Co., UBS Group AG, Wells Fargo & Company, and William Blair.
View the latest analyst ratings for DGX.
What is the current price target for Quest Diagnostics?: 11 Wall Street analysts have set twelve-month price targets for Quest Diagnostics in the last year. Their average twelve-month price target is $150.91, suggesting a possible upside of 6.7%. Mizuho has the highest price target set, predicting DGX will reach $165.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $125.00 for Quest Diagnostics in the next year.
View the latest price targets for DGX.
What is the current consensus analyst rating for Quest Diagnostics?: Quest Diagnostics currently has 1 sell rating, 6 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DGX, but not buy more shares or sell existing shares.
View the latest ratings for DGX.
What other companies compete with Quest Diagnostics?: Other companies that are similar to Quest Diagnostics include Laboratory Co. of America, Exact Sciences, Natera, Molina Healthcare and Koninklijke Philips. Learn More about companies similar to Quest Diagnostics.
How do I contact Quest Diagnostics' investor relations team?: Quest Diagnostics' physical mailing address is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. The medical research company's listed phone number is (973) 520-2700 and its investor relations email address is [email protected] The official website for Quest Diagnostics is www.questdiagnostics.com. Learn More about contacing Quest Diagnostics investor relations.

Quest Diagnostics - DGX Stock Price Target and Predictions

Analyst Price Target for DGX

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.88 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Quest Diagnostics?

What is the current price target for Quest Diagnostics?

What is the current consensus analyst rating for Quest Diagnostics?

What other companies compete with Quest Diagnostics?

How do I contact Quest Diagnostics' investor relations team?